Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity

This publication has 25 references indexed in Scilit:

• Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays
  Contraception, 1995
• Inhibition by nomegestrol acetate and other synthetic progestins on proliferation and progesterone receptor content of T47-D human breast cancer cells
  The Journal of Steroid Biochemistry and Molecular Biology, 1994
• Estrogenic and progestagenic activities coexisting in steroidal drugs: Quantitative evaluation by In vitro bioassays with human cells
  The Journal of Steroid Biochemistry and Molecular Biology, 1994
• Estrogenic actions of RU486 in hormone-responsive MCF-7 human breast cancer cells
  Endocrinology, 1993
• Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism
  British Journal of Cancer, 1993
• One year contraception with a single subdermal implant containing nomegestrol acetate (uniplant)
  Contraception, 1993
• Intrinsic estrogenicity of some progestagenic drugs
  The Journal of Steroid Biochemistry and Molecular Biology, 1992
• Effects of nomegestrol acetate (5 mg/d) on hormonal, metabolic and hemostatic parameters in premenopausal women
  Contraception, 1991
• Growth Stimulation and Differential Regulation of Transforming Growth Factor-β1 (TGFβ1), TGFβ2, and TGFβ3 Messenger RNA Levels by Norethindrone in MCF-7 Human Breast Cancer Cells
  Molecular Endocrinology, 1991
• The effects of the addition of nomegestrol acetate to post-menopausal oestrogen therapy
  Maturitas, 1989